Newton, MA, United States of America

Kaleen Konrad Childers




Average Co-Inventor Count = 10.9

ph-index = 7

Forward Citations = 95(Granted Patents)


Location History:

  • Newton, MA (US) (2013 - 2017)
  • Medfield, MA (US) (2016 - 2017)

Company Filing History:


Years Active: 2013-2017

Loading Chart...
Loading Chart...
Loading Chart...
12 patents (USPTO):

Title: Celebrating the Innovations of Kaleen Konrad Childers

Introduction: Kaleen Konrad Childers, based in Newton, MA, is a distinguished inventor known for her significant contributions to the field of pharmaceutical sciences. With a robust portfolio of 12 patents, Childers has made remarkable strides in developing innovative compounds aimed at treating diseases mediated by Spleen Tyrosine Kinase (Syk).

Latest Patents: Among her latest innovations, two notable patents stand out. The first is titled "Thiazole-substituted aminoheteroaryls as spleen tyrosine kinase inhibitors." This invention provides thiazole-substituted aminoheteroaryl compounds and their pharmaceutically acceptable salts, along with pharmaceutical compositions derived from these compounds. The methods outlined in this patent focus on using these innovative compounds for treating conditions related to Spleen Tyrosine Kinase (Syk).

Her second noteworthy patent is "Thiazole-substituted aminopyridines as spleen tyrosine kinase inhibitors." It features thiazole-substituted aminopyridine compounds and their pharmaceutically acceptable salts, designed for similar therapeutic applications. Together, these patents exemplify Childers' commitment to advancing medical treatments targeting Syk-related diseases.

Career Highlights: Childers has had an impressive career, prominently featuring her tenure at Merck Sharp & Dohme Corporation and Merck Canada Inc. These companies have been instrumental in supporting her research and development efforts, providing a platform for her innovative ideas to flourish.

Collaborations: Throughout her career, Childers has collaborated with notable scientific professionals including Alan B. Northrup and Michael D. Altman. These collaborations have enriched her research endeavors, allowing for a multidisciplinary approach to her inventions.

Conclusion: Kaleen Konrad Childers exemplifies the spirit of innovation in the pharmaceutical industry. Through her extensive patent portfolio and collaborations with leading scientists, she continues to contribute to significant advancements in medical treatments. Her work not only reflects her inventive prowess but also illustrates the vital role of inventors in shaping a healthier future.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…